Does BELIMUMAB Cause Lymphadenopathy? 69 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Lymphadenopathy have been filed in association with BELIMUMAB (BENLYSTA). This represents 0.3% of all adverse event reports for BELIMUMAB.
69
Reports of Lymphadenopathy with BELIMUMAB
0.3%
of all BELIMUMAB reports
1
Deaths
21
Hospitalizations
How Dangerous Is Lymphadenopathy From BELIMUMAB?
Of the 69 reports, 1 (1.4%) resulted in death, 21 (30.4%) required hospitalization.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELIMUMAB. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does BELIMUMAB Cause?
Product dose omission issue (4,671)
Systemic lupus erythematosus (3,388)
Fatigue (1,650)
Drug ineffective (1,570)
Pain (1,510)
Wrong technique in device usage process (1,347)
Injection site pain (1,279)
Malaise (1,257)
Headache (1,207)
Arthralgia (1,114)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which BELIMUMAB Alternatives Have Lower Lymphadenopathy Risk?
BELIMUMAB vs BELINOSTAT
BELIMUMAB vs BELUMOSUDIL
BELIMUMAB vs BELVIQ
BELIMUMAB vs BELZUTIFAN
BELIMUMAB vs BEMPEDOIC ACID